Sage Therapeutics Inc (NASDAQ: SAGE) stock enjoyed a major increase of 12.2% on 12/20/24. The shares closed at $5.61. Moreover, trading volume in this advance was exceptionally high at 455% of normal. The stock has declined -1.1% during the last week and has been extremely weak relative to the market over the last nine months.
Current PriceTarget Research Rating
Sage Therapeutics has a current Value Trend Rating of D (Negative). The Value Trend Rating reflects contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Sage Therapeutics has a slightly positive Appreciation Score of 66 but a poor Power Rating of 20, leading to the Negative Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment